Announcements

Turn Therapeutics Inc. filed a Form S-3 registration statement with the SEC on November 9, 2026, registering up to 25,362,950 shares of common stock for resale by selling stockholders, while also converting two prior Form S-1 registration statements into a single shelf registration.

Compass Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net loss of $27.171 million for the third quarter and a nine-month accumulated deficit surpassing $501 million.

Alon Mualem, Chief Financial Officer of Wearable Devices Ltd., filed a Form 4 on November 9, 2026, disclosing the acquisition of 60,000 Restricted Share Units on November 5, 2026, at no cost under the company's 2024 Global Equity Incentive Plan.

Aric Spitulnik, a newly appointed director of Versus Systems Inc., filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing no securities beneficially owned as of the event date of November 1, 2024.

Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed a Form 4 on November 9, 2026, disclosing the acquisition of 20,000 Restricted Share Units on November 5, 2026.

Livia Desenso Monteiro, HR and Corporate Affairs Officer at Nexa Resources S.A., filed a Form 3 initial statement of beneficial ownership with the SEC on November 9, 2026, reporting no securities beneficially owned.

CorMedix Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026 it entered into an Asset Purchase Agreement with Heron Therapeutics, Inc. to acquire substantially all of Heron's assets for a combination of cash, stock, royalties, and contingent earn-out …